CFTR in K562 human leukemic cells

被引:9
|
作者
Assef, YA
Damiano, AE
Zotta, E
Ibarra, C
Kotsias, BA
机构
[1] Univ Buenos Aires, Inst Invest Med Alfredo Lanari, Fac Med, RA-1427 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Dept Fisiol, Fac Med, RA-1427 Buenos Aires, DF, Argentina
来源
关键词
CFTR; K562; cells; leukemia cells; ion channels; glibenclamide; DIDS; PCR; immunohistochemistry;
D O I
10.1152/ajpcell.00320.2002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this study, the expression and functional characterization of CFTR ( cystic fibrosis transmembrane regulator) was determined in K562 chronic human leukemia cells. Expression of the CFTR gene product was determined by RT-PCR and confirmed by immunohistochemistry and Western blot analysis. Functional characterization of CFTR Cl- channel activity was conducted with patch-clamp techniques. Forskolin, an adenylyl cyclase activator, induced an anion-selective channel with a linear current-voltage relationship and a single-channel conductance of 11 pS. This cAMP-activated channel had a P-gluconate/P-Cl or P-F/P-Cl perm-selectivity ratio of 0.35 and 0.30, respectively, and was inhibited by the CFTR blocker glibenclamide and the anti-CFTR antibody MAb 13-1, when added to the cytoplasmatic side of the patch. Glibenclamide decreased the open probability increasing the frequency of open-to-closed transitions. Addition of 200 muM DIDS caused an irreversible block of the channels when added to the cytosolic side of inside-out patches. These and other observations indicate a widespread distribution of CFTR gene expression and suggest that this channel protein may function in most human cells to help maintain cellular homeostasis.
引用
下载
收藏
页码:C480 / C488
页数:9
相关论文
共 50 条
  • [21] QUANTITATIVE MORPHOLOGICAL ANALYSIS OF ADRIAMYCIN-RESISTANT HUMAN K562 LEUKEMIC-CELLS
    DUFER, J
    AKELI, MG
    JEANNESSON, P
    DESPLACES, A
    JARDILLIER, JC
    CYTOMETRY, 1989, 10 (01): : 37 - 43
  • [22] Curcumin inhibits WT1 gene expression in human leukemic K562 cells
    Songyot ANUCHAPREEDA
    PattraTHANARATTANAKORN
    SomjaiSITTIPREECHACHARN
    Prasit CHANARAT
    Pornngarm LIMTRAKUL
    Acta Pharmacologica Sinica, 2006, (03) : 360 - 366
  • [23] Antioxidative effects of selenium containing imidazole compound, selenoneine, on human leukemic K562 cells
    Seko, T.
    Imamura, S.
    Ishihara, K.
    Yamashita, Y.
    Yamashita, M.
    FEBS OPEN BIO, 2018, 8 : 358 - 358
  • [24] QUANTITATIVE MORPHOLOGICAL ASSESSMENT OF ERYTHROBLASTIC DIFFERENTIATION INDUCED, INVITRO, IN HUMAN K562 LEUKEMIC-CELLS
    BROGLIO, C
    DUFER, J
    JOLY, P
    CARPENTIER, Y
    DESPLACES, A
    ANALYTICAL CELLULAR PATHOLOGY, 1993, 5 (03): : 135 - 146
  • [25] Rilmenidine suppresses proliferation and promotes apoptosis via the mitochondrial pathway in human leukemic K562 cells
    Srdic-Rajic, Tatjana
    Nikolic, Katarina
    Cavic, Milena
    Djokic, Ivana
    Gemovic, Branislava
    Perovic, Vladimir
    Veljkovic, Nevena
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 81 : 172 - 180
  • [26] An Enhancer LncRNA Regulates NFE2 Expression and Proliferation in Human Leukemic K562 Cells*
    Lu, Yan-Fei
    Qu, Song-Ya
    Zhu, Jing-Jing
    Liu, Chao
    Wang, Jian
    Han, Bing-She
    Zhang, Jun-Fang
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2024, 51 (01) : 190 - 201
  • [27] ADRIAMYCIN RESISTANCE IN CHARACTERIZED BY ULTRASTRUCTURAL-CHANGES IN HUMAN LEUKEMIC K562 CELLS-INVITRO
    BOBICHON, H
    OKIEMI, MG
    BROGLIO, C
    PLOTON, D
    DUFER, J
    BIOLOGY OF THE CELL, 1992, 74 (03) : 287 - 297
  • [28] Retroviral gene transfer of interferon alpha into leukemic K562 cells.
    Lutton, JD
    Marriott, R
    Quan, S
    BLOOD, 1997, 90 (10) : 4614 - 4614
  • [29] Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells
    Mould, Richard
    Pondel, Marc D.
    CANCER CELL INTERNATIONAL, 2003, 3 (1)
  • [30] Sorbitol-induced apoptosis in chronic myelogenous leukemic K562 cells
    Marfè, G
    Di Stefano, C
    Giancotti, P
    Alberto, C
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 273A - 273A